Diligence memo · auto-generated · as of July 2, 2026

Crop Diagnostix, Inc.

Crop Diagnostix, Inc. looks fair against its niche peers and is quiet on financing cadence.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

Crop Diagnostix, Inc. operates in Healthtech, based in SAN DIEGO.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Crop Diagnostix, Inc. has raised $3.5M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $3.5M on 2024-11-26.

Most recent recorded round closed around 2024-11-26.

Valuation (modeled)modeled

Provath models Crop Diagnostix, Inc. at approximately $13M (range $3.0M–$32M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.07× the median modeled value of Seed Healthtech companies in 2022–2024 (162 peers) — value vs value, same stage and era. Within the normal band (107% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 19 mo ago; this sector typically re-raises about every 14 months.

Slightly overdue versus sector cadence.

Comparablesmixed

Capital scale ranks ahead of 49% of Healthtech peers (2138 compared).

Modeled value ranks above 37% of those peers.

Closest niche peers: NJ Shore Wellness LLC, Neb Health Inc, Aerwave Medical, Inc., Oya Care Ltd, Aam Care, Inc..

Peoplefiled

5 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.